|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 21 Feb 2019
|
|
Related companies:
Bavarian Nordic A/S |
Bavarian Nordic GmbH |
|
|
- Data presented at ATTD confirms previous analyses that higher rates of scanning with the FreeStyle Libre system are strongly associated with improved glucose control Read more ›› |
|
By: PR Newswire Association LLC. - 21 Feb 2019
|
|
Related companies:
Abbott GmbH & Co. KG |
|
|
GOTHENBURG, Sweden and ZUG, Switzerland, Feb. 21, 2019 /PRNewswire/ -- POA Pharma Scandinavia AB, a market-oriented Boutique Healthcare Company, working in close contact with healthcare organizations, professionals and hospitals in Nordic countries and Primex Pharmaceuticals AG, an innovative... Read more ›› |
|
By: PR Newswire Association LLC. - 21 Feb 2019
|
|
|
ABBOTT PARK, Ill., Feb. 20, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface antigen, the Read more ›› |
|
By: PR Newswire Association LLC. - 20 Feb 2019
|
|
Related companies:
Abbott GmbH & Co. KG |
|
|
ABBOTT PARK, Ill. and BAGSVÆRD, Denmark, Feb. 20, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible... Read more ›› |
|
By: PR Newswire Association LLC. - 20 Feb 2019
|
|
Related companies:
Abbott GmbH & Co. KG |
|
|
LYON, France, Feb. 20, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 20 Feb 2019
|
|
Related companies:
Novasep Leverkusen site (Dynamit Nobel GmbH Explosivstoff- und Systemtechnik) |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 19 Feb 2019
|
|
Related companies:
CureVac AG |
|
|
- Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Read more ›› |
|
By: PR Newswire Association LLC. - 19 Feb 2019
|
|
Related companies:
Merck KGaA |
Merck Chemicals GmbH |
Merck Serono GmbH |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 18 Feb 2019
|
|
Related companies:
Curetis AG |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 18 Feb 2019
|
|
Related companies:
Össur Nordic AB |
Össur Germany GmbH |
Össur Americas, Inc. |
|
|
PARIS, February 18, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 18 Feb 2019
|
|
|
Not intended for US, Canada and UK-based media Read more ›› |
|
By: PR Newswire Association LLC. - 18 Feb 2019
|
|
Related companies:
Merck KGaA |
Merck Chemicals GmbH |
Merck Serono GmbH |
|
|
HENNIGSDORF, Germany, Feb. 15, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 15 Feb 2019
|
|
Related companies:
sphingotec GmbH |
|
|
JINING, China, Feb. 14, 2019 /PRNewswire/ -- Spring Pharmaceutical Group, Inc. (OTCQB: CYIG) ("Spring Pharmaceutical" or the "Company") today announced its financial results for the three and nine months ended December 31, 2018. Read more ›› |
|
By: PR Newswire Association LLC. - 14 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 14 Feb 2019
|
|
Related companies:
Össur Nordic AB |
Össur Germany GmbH |
Össur Americas, Inc. |
|
|
GYEONGGI, South Korea, Feb. 14, 2019 /PRNewswire/ -- SK Biopharmaceuticals and Arvelle Therapeutics GmbH today announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe. Cenobamate is a novel, small molecule investigational... Read more ›› |
|
By: PR Newswire Association LLC. - 14 Feb 2019
|
|
|
DÜSSELDORF, Germany, February 14, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 14 Feb 2019
|
|
|
PARIS, February 14, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 14 Feb 2019
|
|
|
SINGAPORE, Feb. 14, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced that the Singapore Health Sciences Authority has approved Biktarvy® (bictegravir 50mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg; BIC/FTC/TAF), a once-daily single tablet regimen (STR) for the treatment of HIV-1... Read more ›› |
|
By: PR Newswire Association LLC. - 14 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 13 Feb 2019
|
|
|
|
|
|
Biotechgate Global Database ›
